Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 7 | 2020 | 100 | 0.930 |
Why?
|
| Students, Medical | 2 | 2020 | 424 | 0.930 |
Why?
|
| Vena Cava, Inferior | 7 | 2020 | 148 | 0.850 |
Why?
|
| Career Choice | 2 | 2020 | 148 | 0.740 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2024 | 402 | 0.720 |
Why?
|
| Embolization, Therapeutic | 5 | 2024 | 265 | 0.700 |
Why?
|
| Device Removal | 6 | 2020 | 169 | 0.660 |
Why?
|
| Medicine | 1 | 2020 | 91 | 0.650 |
Why?
|
| Liver Neoplasms | 5 | 2024 | 760 | 0.610 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 539 | 0.470 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 651 | 0.460 |
Why?
|
| Prosthesis Implantation | 3 | 2020 | 129 | 0.430 |
Why?
|
| Radiology, Interventional | 3 | 2021 | 70 | 0.380 |
Why?
|
| Renal Dialysis | 3 | 2021 | 338 | 0.350 |
Why?
|
| Radiography, Interventional | 5 | 2020 | 157 | 0.340 |
Why?
|
| Arteriovenous Fistula | 2 | 2021 | 53 | 0.340 |
Why?
|
| Catheter Ablation | 2 | 2022 | 256 | 0.320 |
Why?
|
| Pulmonary Embolism | 3 | 2020 | 237 | 0.320 |
Why?
|
| Yttrium Radioisotopes | 3 | 2024 | 59 | 0.280 |
Why?
|
| Angioplasty | 2 | 2019 | 70 | 0.270 |
Why?
|
| Tumor Burden | 2 | 2024 | 316 | 0.260 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2021 | 241 | 0.250 |
Why?
|
| Angiography | 3 | 2021 | 208 | 0.250 |
Why?
|
| Treatment Outcome | 15 | 2024 | 8373 | 0.240 |
Why?
|
| Ultrasonography, Interventional | 2 | 2024 | 126 | 0.240 |
Why?
|
| Computed Tomography Angiography | 3 | 2021 | 155 | 0.230 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2024 | 44 | 0.230 |
Why?
|
| SEER Program | 1 | 2024 | 201 | 0.220 |
Why?
|
| Cholangiocarcinoma | 1 | 2024 | 81 | 0.220 |
Why?
|
| Microspheres | 1 | 2024 | 108 | 0.220 |
Why?
|
| Bile Duct Neoplasms | 1 | 2024 | 95 | 0.220 |
Why?
|
| Radiopharmaceuticals | 1 | 2024 | 198 | 0.200 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2022 | 35 | 0.200 |
Why?
|
| Workload | 2 | 2020 | 130 | 0.190 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 2667 | 0.190 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2021 | 10 | 0.190 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2021 | 16 | 0.190 |
Why?
|
| Brachiocephalic Veins | 1 | 2021 | 34 | 0.190 |
Why?
|
| Humans | 27 | 2024 | 90568 | 0.180 |
Why?
|
| Hospital Units | 1 | 2020 | 30 | 0.180 |
Why?
|
| Catheterization, Peripheral | 1 | 2021 | 60 | 0.180 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 25 | 0.180 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 30 | 0.170 |
Why?
|
| Hepatic Artery | 1 | 2021 | 84 | 0.170 |
Why?
|
| Aneurysm, False | 1 | 2020 | 55 | 0.170 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 54 | 0.170 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 80 | 0.170 |
Why?
|
| Brachytherapy | 1 | 2021 | 121 | 0.170 |
Why?
|
| Work-Life Balance | 1 | 2019 | 6 | 0.170 |
Why?
|
| Female | 16 | 2024 | 46855 | 0.170 |
Why?
|
| Disease Progression | 1 | 2024 | 1485 | 0.160 |
Why?
|
| Retrospective Studies | 11 | 2024 | 9323 | 0.160 |
Why?
|
| Sexism | 1 | 2019 | 55 | 0.160 |
Why?
|
| Social Media | 1 | 2020 | 98 | 0.150 |
Why?
|
| Mentors | 1 | 2019 | 92 | 0.150 |
Why?
|
| Hemodynamics | 1 | 2021 | 739 | 0.150 |
Why?
|
| Medicare | 1 | 2021 | 429 | 0.150 |
Why?
|
| Hemorrhage | 1 | 2019 | 290 | 0.140 |
Why?
|
| Motivation | 1 | 2020 | 303 | 0.140 |
Why?
|
| Time Factors | 6 | 2024 | 5365 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2021 | 1103 | 0.140 |
Why?
|
| Fluoroscopy | 3 | 2024 | 130 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2020 | 591 | 0.130 |
Why?
|
| Sex Factors | 1 | 2019 | 1074 | 0.130 |
Why?
|
| Male | 13 | 2024 | 42931 | 0.130 |
Why?
|
| Mesenteric Arteries | 1 | 2015 | 29 | 0.130 |
Why?
|
| Middle Aged | 12 | 2024 | 26327 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 476 | 0.120 |
Why?
|
| Aged | 11 | 2024 | 19404 | 0.120 |
Why?
|
| Stents | 2 | 2020 | 415 | 0.120 |
Why?
|
| Prosthesis Design | 4 | 2019 | 307 | 0.120 |
Why?
|
| Prosthesis Failure | 1 | 2014 | 119 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 2015 | 2342 | 0.110 |
Why?
|
| Aged, 80 and over | 6 | 2024 | 6812 | 0.110 |
Why?
|
| Risk Factors | 5 | 2024 | 5580 | 0.110 |
Why?
|
| Catheters, Indwelling | 2 | 2013 | 114 | 0.100 |
Why?
|
| Catheterization, Central Venous | 2 | 2013 | 116 | 0.100 |
Why?
|
| Endoleak | 1 | 2012 | 41 | 0.100 |
Why?
|
| Hemostatics | 1 | 2012 | 58 | 0.100 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2012 | 120 | 0.090 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 260 | 0.090 |
Why?
|
| Chicago | 3 | 2019 | 1440 | 0.080 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 822 | 0.070 |
Why?
|
| Adult | 7 | 2024 | 26940 | 0.070 |
Why?
|
| Young Adult | 4 | 2021 | 6425 | 0.070 |
Why?
|
| Constriction, Pathologic | 2 | 2021 | 222 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 2013 | 1179 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 417 | 0.060 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2024 | 16 | 0.060 |
Why?
|
| Phlebography | 2 | 2016 | 70 | 0.060 |
Why?
|
| Operative Time | 1 | 2024 | 151 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2024 | 2335 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 154 | 0.050 |
Why?
|
| Adolescent | 3 | 2021 | 9353 | 0.050 |
Why?
|
| Pulsatile Flow | 1 | 2021 | 51 | 0.050 |
Why?
|
| Brachial Artery | 1 | 2021 | 37 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 3692 | 0.050 |
Why?
|
| Microwaves | 1 | 2021 | 36 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2021 | 199 | 0.050 |
Why?
|
| Retreatment | 1 | 2021 | 107 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 59 | 0.040 |
Why?
|
| Mechanical Thrombolysis | 1 | 2020 | 16 | 0.040 |
Why?
|
| United States | 2 | 2024 | 7142 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 81 | 0.040 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 98 | 0.040 |
Why?
|
| Hypotension | 1 | 2020 | 71 | 0.040 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2019 | 38 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2020 | 117 | 0.040 |
Why?
|
| Radiation Exposure | 1 | 2019 | 25 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 2019 | 0.040 |
Why?
|
| Mortality | 1 | 2020 | 148 | 0.040 |
Why?
|
| Contrast Media | 1 | 2024 | 1085 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2019 | 118 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2019 | 230 | 0.040 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 146 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2020 | 193 | 0.040 |
Why?
|
| Aspirin | 1 | 2019 | 162 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 2702 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 246 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2782 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 243 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 602 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 846 | 0.030 |
Why?
|
| Recurrence | 1 | 2020 | 1162 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2020 | 440 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1357 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2015 | 159 | 0.030 |
Why?
|
| Models, Biological | 1 | 2021 | 1770 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1882 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2013 | 73 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 1899 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1594 | 0.020 |
Why?
|